Optum notable drugs nearing FDA approval include Anaphylm, Sotyktu, and insulin icodec with decisions expected early 2026.

Senators are calling UnitedHealth Group’s response to an investigation "inadequate" and demanding more information following ...

Health insurance companies are expected to hold to their promises in 2026 to “streamline, simplify and reduce” prior authorization, the process of approving medical care.

UnitedHealth Group, Inc’s. UNH Optum Rx is expanding its offerings for patients with the introduction of two additional HUMIRA biosimilars. Effective Jul 1, Optum Rx will offer three biosimilar ...

A contract termination between Optum and Humana, as well as the expiration of enhanced tax credits for people covered by ...